嘉士利集團(01285.HK)2024年收益同比增加約6.9%至18.03億元
格隆匯3月21日丨嘉士利集團(01285.HK)公告,集團於2024年的收益同比增加約6.9%至約人民幣18.03億元。2024年公司擁有人應佔溢利約爲人民幣5450萬元,同比跌幅爲14.8%。每股盈利基本及攤薄13.12人民幣分。
出於物美價廉及客戶零投訴的追求,集團提高產品品質和原材料供應,同時改進品質和供應管理以及生產包裝過程。透過對產品安全的嚴格控制,品質檢查和評審將在生產的每個階段落實,從而降低成本,提高生產效率。
年內,公司持續爲客戶提供支持,快速靈活地應對不斷迭加的挑戰,從而取得亮眼的表現。能夠取得如此成功,這證明瞭公司作爲一家企業的韌性、精心規劃及靈活性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.